XML 58 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements Of Cash Flows (USD $)
In Millions
3 Months Ended
Sep. 30, 2011
Sep. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:  
Net earnings$ 236.8$ 294.8
(Earnings)/loss from discontinued operations0.3(0.4)
Earnings from continuing operations237.1294.4
Adjustments to reconcile earnings from continuing operations to net cash from operations:  
Depreciation and amortization78.268.5
Gain on sale of investment in CareFusion0(74.8)
Impairments and loss on sale of assets1.31.9
Share-based compensation19.821.4
Provision for bad debts0.92.7
Change in operating assets and liabilities, net of effects from acquisitions:  
Increase in trade receivables(69.3)(272.3)
Increase in inventories(160.9)(731.8)
Increase in accounts payable409.81,033.1
Other accrued liabilities and operating items, net(12.7)(125.4)
Net cash provided by operating activities-continuing operations504.2217.7
Net cash used in operating activities-discontinued operations0(0.7)
Net cash provided by operating activities504.2217.0
CASH FLOWS FROM INVESTING ACTIVITIES:  
Acquisition of subsidiaries, net of cash acquired(7.3)(559.9)
Additions to property and equipment(44.3)(61.9)
Proceeds from sale of CareFusion common stock0705.9
Proceeds from maturities of held-to-maturity securities10.00
Net cash provided by /(used in) investing activities-continuing operations(41.6)84.1
Net cash provided by investing activities-discontinued operations00
Net cash provided by/(used in) investing activities(41.6)84.1
CASH FLOWS FROM FINANCING ACTIVITIES:  
Net change in short-term borrowings(5.0)0
Reduction of long-term obligations(0.5)(0.4)
Proceeds from issuance of Common Shares18.18.4
Tax disbursements from share-based compensation(21.6)(14.1)
Excess tax benefit from exercises of stock options4.92.0
Dividends on Common Shares(77.2)(70.3)
Purchase of treasury shares(300.0)(269.8)
Net cash used in financing activities-continuing operations(381.3)(344.2)
Net cash provided by financing activities-discontinued operations00
Net cash used in financing activities(381.3)(344.2)
NET INCREASE/(DECREASE) IN CASH AND EQUIVALENTS81.3(43.1)
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD1,929.32,755.3
CASH AND EQUIVALENTS AT END OF PERIOD$ 2,010.6$ 2,712.2